Recent studies have shown temporal increase of neutralizing antibody potency and breadth to SARS-CoV-2 variants in convalescent individuals. Here, we found a similar process after Sputnik V vaccination. We examined longitudinal antibody responses and viral neutralizing capacity to variants of concern (VOC: Alpha, Beta, Gamma and Delta) and a broadly spread variant of interest (VOI: Lambda) in volunteers up to 6 months of receiving Sputnik V vaccine in Argentina. A collection of 1800 serum samples obtained between January and August 2021 were used. The analysis indicates that while anti-spike IgG levels significantly wane over time, neutralizing potency against the original SARS-CoV-2 and VOC increase within four months of vaccination, sugge...
[[abstract]]Background: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 be...
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has raised co...
[[abstract]]Background: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 be...
Recent studies have shown temporal increase of neutralizing antibody potency and breadth to SARS-CoV...
Recent studies have shown a temporal increase in the neutralizing antibody potency and breadth to SA...
Massive vaccination offers great promise for halting the global COVID-19 pandemic. However, limited ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve in humans. Spike pr...
Massive vaccination offers great promise for halting the global COVID-19 pandemic. However, limited ...
Background: The continuous emergence of SARS-CoV-2 variants of concern (VOC) with immune escape prop...
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response an...
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response an...
Background: The continuous emergence of SARS-CoV-2 variants of concern (VOC) with immune escape prop...
Infection-neutralizing antibody responses after SARS-CoV-2 infection or COVID-19 vaccination are an ...
Abstract Two-dose messenger RNA vaccines against the severe acute respiratory syndrome coronavirus 2...
Abstract A number of SARS-CoV-2 variants of concern (VOC) have been identified that partially escape...
[[abstract]]Background: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 be...
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has raised co...
[[abstract]]Background: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 be...
Recent studies have shown temporal increase of neutralizing antibody potency and breadth to SARS-CoV...
Recent studies have shown a temporal increase in the neutralizing antibody potency and breadth to SA...
Massive vaccination offers great promise for halting the global COVID-19 pandemic. However, limited ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve in humans. Spike pr...
Massive vaccination offers great promise for halting the global COVID-19 pandemic. However, limited ...
Background: The continuous emergence of SARS-CoV-2 variants of concern (VOC) with immune escape prop...
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response an...
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response an...
Background: The continuous emergence of SARS-CoV-2 variants of concern (VOC) with immune escape prop...
Infection-neutralizing antibody responses after SARS-CoV-2 infection or COVID-19 vaccination are an ...
Abstract Two-dose messenger RNA vaccines against the severe acute respiratory syndrome coronavirus 2...
Abstract A number of SARS-CoV-2 variants of concern (VOC) have been identified that partially escape...
[[abstract]]Background: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 be...
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has raised co...
[[abstract]]Background: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 be...